LAURA MACKLEY: Open Payments
NPI 1558622100 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 44 payments from 11 companies in 2025. Trend: 2023 $1,244 · 2024 $959 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $228 |
| AstraZeneca Pharmaceuticals LP | 6 | $214 |
| ABBVIE INC. | 11 | $196 |
| Novo Nordisk Inc | 5 | $121 |
| GlaxoSmithKline, LLC. | 5 | $78 |
| Abbott Laboratories | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: NURTEC ODT, AIRSUPRA, FARXIGA, UBRELVY, VRAYLAR, TRELEGY ELLIPTA, Wegovy, Ozempic.
Industry payments across FL — which companies pay providers there.
